Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
X4 Pharmaceuticals Inc
10.70M
5.47M
2.49%
57.89%
5.44%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
BOSTON